Main Stream Gastroenterology

Main Stream Gastroenterology Practical and academic page specialized in Hepato-gastroenterology and endoscopy

كل عام وحضراتكم جميعا بخير وصحة وسعادة
15/06/2024

كل عام وحضراتكم جميعا بخير وصحة وسعادة

AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert ReviewBest Prac...
19/11/2023

AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review

Best Practice Advice Statements
Best Practice Advice 1
Vasoactive drugs should be initiated as soon as the diagnosis of variceal hemorrhage is suspected or confirmed, preferably before diagnostic and/or therapeutic endoscopy.
Best Practice Advice 2
After initial endoscopic hemostasis, vasoactive drugs should be continued for 2–5 days to prevent early rebleeding.
Best Practice Advice 3
Octreotide is the vasoactive drug of choice in the management of variceal hemorrhage based on its safety profile.
Best Practice Advice 4
IV albumin should be administered at the time of large-volume (>5 L) paracentesis.
Best Practice Advice 5
IV albumin may be considered in patients with SBP.
Best Practice Advice 6
Albumin should not be used in patients (hospitalized or not) with cirrhosis and uncomplicated ascites.
Best Practice Advice 7
Vasoconstrictors should not be used in the management of uncomplicated ascites, after large-volume paracentesis or in patients with SBP.
Best Practice Advice 8
IV albumin is the volume expander of choice in hospitalized patients with cirrhosis and ascites presenting with AKI.
Best Practice Advice 9
Vasoactive drugs (eg, terlipressin, norepinephrine, and combination of octreotide and midodrine) should be used in the treatment of HRS-AKI, but not in other forms of AKI in cirrhosis.
Best Practice Advice 10
Terlipressin is the vasoactive drug of choice in the treatment of HRS-AKI and use of concurrent albumin can be considered when accounting for patient’s volume status.
Best Practice Advice 11
Terlipressin treatment does not require intensive care unit monitoring and can be administered intravenously through a peripheral line.
Best Practice Advice 12
Terlipressin use is contraindicated in patients with hypoxemia and in patients with ongoing coronary, peripheral, or mesenteric ischemia, and should be used with caution in patients with acute-on-chronic liver failure grade 3. The benefits may not outweigh the risks in patients with serum creatinine >5 mg/dL and in patients listed for transplantation with a Model for End-stage Liver Disease ≥35.

Link for full text :

https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2823%2905143-0

Thanks for our sponsors 🌹🌹
25/08/2023

Thanks for our sponsors 🌹🌹

Research course AHC
21/08/2023

Research course
AHC

Meet our Faculty of “Therapeutic Advances in Hepatogastroenterology” ; the official congress of Main Stream Gastroente...
14/08/2023

Meet our Faculty of

“Therapeutic Advances in Hepatogastroenterology”

; the official congress of Main Stream Gastroenterology Foundation; will be held between 20th-25th of August 2023 (Sunday-Friday).

Registration link:

https://tanzeem-iom.com/aec_events/ahc2023/

To keep updated and to register, follow our Telegram Group:

https://t.me/+GFnqyCCoR341OWU0

Official Organizer: Tanzeem IOM
Waiting for you,

AHC2023 Board

Register for our premium annual workshops.1- Ultrasound & FIBROSCAN/ CAP2- Research Workshop 3- Live Endoscopy Worksho...
10/08/2023


Register for our premium annual workshops.

1- Ultrasound & FIBROSCAN/ CAP
2- Research Workshop
3- Live Endoscopy Workshop

Enjoy hands-on training, a comprehensive reasech training program and exceptional live endoscopy with GI Endoscopy stars.

Numbers are limited to 50 participants only for each workshop.
Register through the following link:

https://tanzeem-iom.com/ahc-2023-workshops/

Waiting for you all.
MSG Board

If you have missed it last year, DO NOT MISS IT IN 2023“Therapeutic Advances in Hepatogastroenterology” ; the official ...
09/08/2023

If you have missed it last year, DO NOT MISS IT IN 2023
“Therapeutic Advances in Hepatogastroenterology”

; the official congress of Main Stream Gastroenterology Foundation; will be held between 20th-25th of August 2023 (Sunday-Friday).

Registration link:

https://tanzeem-iom.com/aec_events/ahc2023/

To keep updated and to register, follow our Telegram Group:

https://t.me/+GFnqyCCoR341OWU0

Official Organizer: Tanzeem IOM
Waiting for you,

AHC2023 Board

If you have missed it last year, DO NOT MISS IT IN 2023“Therapeutic Advances in Hepatogastroenterology” ; the official ...
11/07/2023

If you have missed it last year, DO NOT MISS IT IN 2023
“Therapeutic Advances in Hepatogastroenterology”

; the official congress of Main Stream Gastroenterology Foundation; will be held between 20th-25th of August 2023 (Sunday-Friday).

Registration link:

https://tanzeem-iom.com/aec_events/ahc2023/

To keep updated and to register, follow our Telegram Group:

https://t.me/+GFnqyCCoR341OWU0

Official Organizer: Tanzeem IOM
Waiting for you,

AHC2023 Board

Address

Gohar El Qaed
Cairo
11651

Telephone

+201155019700

Website

Alerts

Be the first to know and let us send you an email when Main Stream Gastroenterology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category